Busen Wang
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
- Health top 2%
- Vaccine Coverage and Hesitancy
Papers in
-
- SARS-CoV-2 and COVID-19 Research 13
- Viral gastroenteritis research and epidemiology 4
- COVID-19 Clinical Research Studies 4
- Viral Infections and Outbreaks Research 4
- Genetics 12
- Virus-based gene therapy research 12
- Co-authors
- Shipo Wu (14 shared papers)Xiaohong Song (9 shared papers)Lihua Hou (13 shared papers)Wei Chen (5 shared papers)Jinlong Zhang (10 shared papers)Zhe Zhang (8 shared papers)Yu Wang (5 shared papers)Tao Zhu (2 shared papers)
In The Last Decade
Busen Wang
25 papers receiving 1.7k citations
Busen Wang's Hit Papers
Peers
Comparison fields: 5 of 94
- Infectious Diseases 1.3k
- Health 283
- Animal Science and Zoology 182
- Modeling and Simulation 68
- Immunology 237
Countries citing papers authored by Busen Wang
This map shows the geographic impact of Busen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Busen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Busen Wang more than expected).
Fields of papers citing papers by Busen Wang
This network shows the impact of papers produced by Busen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Busen Wang. The network helps show where Busen Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Busen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial Hit paper breakdown → | 2020 | 963 |
| 2 | Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial Hit paper breakdown → | 2021 | 239 |
| 3 | 2020 | 227 | |
| 4 | 2018 | 107 | |
| 5 | 2018 | 48 | |
| 6 | 2023 | 46 | |
| 7 | 2022 | 18 | |
| 8 | 2022 | 17 | |
| 9 | 2017 | 16 | |
| 10 | 2023 | 14 | |
| 11 | 2023 | 12 | |
| 12 | 2022 | 11 | |
| 13 | 2023 | 9 | |
| 14 | 2024 | 9 | |
| 15 | 2022 | 9 | |
| 16 | 2022 | 6 | |
| 17 | 2023 | 5 | |
| 18 | 2023 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2025 | 2 |
About Busen Wang
Busen Wang is a scholar working on Infectious Diseases, Genetics, Animal Science and Zoology, Epidemiology and Immunology, having authored 26 papers that have together received 1.8k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (13 papers), Virus-based gene therapy research (12 papers), Viral gastroenteritis research and epidemiology (4 papers), COVID-19 Clinical Research Studies (4 papers), Viral Infections and Outbreaks Research (4 papers), Animal Virus Infections Studies (3 papers), Immunotherapy and Immune Responses (2 papers) and Viral Infections and Immunology Research (2 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), Health (283 citations), Animal Science and Zoology (182 citations), Modeling and Simulation (68 citations) and Immunology (237 citations). Busen Wang has collaborated with scholars based in China, Czechia and Hong Kong. Frequent co-authors include Shipo Wu, Xiaohong Song, Lihua Hou, Wei Chen, Jinlong Zhang, Zhe Zhang, Yu Wang, Tao Zhu, Lin Luo and Hanning Hu. Their work appears in journals such as Frontiers in Immunology, Emerging Microbes & Infections, Frontiers in Microbiology, Nature Communications and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.